Back

XAPASS: Evidence of Safety and Effectiveness in Japanese Patients Treated with Rivaroxaban for Stroke Prevention in Atrial Fibrillation under Real-World Clinical Practice

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Registries atrial fibrillation Stroke ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Takanori Ikeda

Toho University, Tokyo (Japan)

5 More presentations in this session

Presentation thumbnail
Identifying patients with atrial fibrillation and "truly low" thromboembolic risk who are poorly characterized by CHA2DS2-VASc: Superior performance of a novel machine learning tool in GARFIELD-AF
Professor K. Fox (Edinburgh, GB)
Slides Video
Presentation thumbnail
A nationwide register study to compare bleeding rates in patients with non-valvular atrial fibrillation prescribed oral anticoagulants
Professor S. Halvorsen (Oslo, NO)
Slides Video
Presentation thumbnail
ESC-EURObservational Research Programme: In-hospital and 1-year follow-up of the Long-term Atrial Fibrillation Ablation Registry, Conducted by the European Heart Rhythm Association
Associate Professor E. Arbelo (Barcelona, ES)
Slides Video
Presentation thumbnail
Association of Inappropriate Dosing of Non-Vitamin K Oral Anticoagulants and Risk of Adverse Events: Results from the ORBIT-AF II Registry
Professor J. Piccini (Durham, US)
Slides Video
Presentation thumbnail
A Large-Scale Multi-Center Registry of Patients Undergoing Radiofrequency Catheter Ablation for Atrial Fibrillation: Kansai Plus Atrial Fibrillation Study
Doctor S. Shizuta (Wakayama, JP)
Slides Video

Access the full session

Session thumbnail
Registries atrial fibrillation

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources